EVGO INC (EVGO)

US30052F1003 - Common Stock

3.965  -0.17 (-4%)

Fundamental Rating

2

Overall EVGO gets a fundamental rating of 2 out of 10. We evaluated EVGO against 119 industry peers in the Specialty Retail industry. EVGO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EVGO is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year EVGO has reported negative net income.
EVGO had a negative operating cash flow in the past year.
EVGO had negative earnings in each of the past 5 years.
In the past 5 years EVGO always reported negative operating cash flow.

1.2 Ratios

EVGO's Return On Assets of -5.55% is on the low side compared to the rest of the industry. EVGO is outperformed by 70.94% of its industry peers.
Industry RankSector Rank
ROA -5.55%
ROE N/A
ROIC N/A
ROA(3y)-3.25%
ROA(5y)-14.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 9.67%, EVGO is not doing good in the industry: 94.87% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for EVGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

EVGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVGO has more shares outstanding
EVGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EVGO has an Altman-Z score of 0.02. This is a bad value and indicates that EVGO is not financially healthy and even has some risk of bankruptcy.
EVGO has a worse Altman-Z score (0.02) than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACC10.34%

2.3 Liquidity

EVGO has a Current Ratio of 2.19. This indicates that EVGO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.19, EVGO belongs to the best of the industry, outperforming 82.05% of the companies in the same industry.
EVGO has a Quick Ratio of 2.19. This indicates that EVGO is financially healthy and has no problem in meeting its short term obligations.
EVGO's Quick ratio of 2.19 is amongst the best of the industry. EVGO outperforms 94.02% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.19

6

3. Growth

3.1 Past

The earnings per share for EVGO have decreased by -2.44% in the last year.
EVGO shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.08%.
EVGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 122.66% yearly.
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
Revenue 1Y (TTM)73.08%
Revenue growth 3Y122.66%
Revenue growth 5YN/A
Sales Q2Q%92.37%

3.2 Future

EVGO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.86% yearly.
The Revenue is expected to grow by 44.73% on average over the next years. This is a very strong growth
EPS Next Y18.62%
EPS Next 2Y16.8%
EPS Next 3Y16.55%
EPS Next 5Y10.86%
Revenue Next Year67.03%
Revenue Next 2Y52.04%
Revenue Next 3Y44.71%
Revenue Next 5Y44.73%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVGO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EVGO's earnings are expected to grow with 16.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.8%
EPS Next 3Y16.55%

0

5. Dividend

5.1 Amount

No dividends for EVGO!.
Industry RankSector Rank
Dividend Yield N/A

EVGO INC

NASDAQ:EVGO (1/10/2025, 12:40:59 PM)

3.965

-0.17 (-4%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners45.44%
Inst Owner Change0%
Ins Owners0.77%
Ins Owner Change15.73%
Market Cap1.20B
Analysts81.18
Price Target8.31 (109.58%)
Short Float %36.02%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.57%
Min EPS beat(2)-16.94%
Max EPS beat(2)-12.2%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-16.94%
Max EPS beat(4)36.44%
EPS beat(8)6
Avg EPS beat(8)29.17%
EPS beat(12)8
Avg EPS beat(12)36.4%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.2%
Min Revenue beat(2)0.39%
Max Revenue beat(2)10.01%
Revenue beat(4)4
Avg Revenue beat(4)6.23%
Min Revenue beat(4)0.39%
Max Revenue beat(4)11.31%
Revenue beat(8)7
Avg Revenue beat(8)15.4%
Revenue beat(12)8
Avg Revenue beat(12)6.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.52%
PT rev (3m)46.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.06%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-1.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.79
BVpS-1.14
TBVpS-1.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.67%
FCFM N/A
ROA(3y)-3.25%
ROA(5y)-14.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 167.56%
Cap/Sales 44.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.19
Altman-Z 0.02
F-Score4
WACC10.34%
ROIC/WACCN/A
Cap/Depr(3y)378.42%
Cap/Depr(5y)296.55%
Cap/Sales(3y)252.74%
Cap/Sales(5y)202.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
EPS Next Y18.62%
EPS Next 2Y16.8%
EPS Next 3Y16.55%
EPS Next 5Y10.86%
Revenue 1Y (TTM)73.08%
Revenue growth 3Y122.66%
Revenue growth 5YN/A
Sales Q2Q%92.37%
Revenue Next Year67.03%
Revenue Next 2Y52.04%
Revenue Next 3Y44.71%
Revenue Next 5Y44.73%
EBIT growth 1Y14.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.28%
EBIT Next 3Y32.99%
EBIT Next 5Y26.63%
FCF growth 1Y52.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y97.54%
OCF growth 3YN/A
OCF growth 5YN/A